Infectious Disease

Top Story

Study identifies cardiopulmonary contributors to death in COVID-19

May 29, 2020
Feature

Q&A: Remdesivir a ‘go-to’ COVID-19 treatment, but questions remain

May 29, 2020
Last month, Anthony S. Fauci, MD, announced unpublished data from a phase 3 trial that showed remdesivir shortened the time to recovery for patients with COVID-19 from…

AstraZeneca donates $1.1 million to AKF’s COVID-19 emergency fund

May 29, 2020
Pharmaceutical company AstraZeneca has donated $1.1 million to the American Kidney Fund’s coronavirus emergency relief program
Feature

Large study adds to questions about safety, usefulness of hydroxychloroquine for COVID-19

May 29, 2020
In late March, the FDA authorized emergency use of hydroxychloroquine for COVID-19. It later approved an abbreviated new drug application for the drug in response to a…
In the Journals

Confirmed ischemic stroke rates low in COVID-19

May 29, 2020
Patients hospitalized with COVID-19 had low rates of ischemic stroke confirmed by imaging, according to a study published in Stroke. The study also found that most…
More Headlines »
CME

HIV Curbside Consults, Volume IV: Switching ART Regimens in Patients Who Become Intolerant

This activity is supported by an educational grant from ViiV Healthcare.

More »
Feature

Q&A: Remdesivir a ‘go-to’ COVID-19 treatment, but questions remain

May 29, 2020
Last month, Anthony S. Fauci, MD, announced unpublished data from a phase 3 trial that showed remdesivir shortened the…
More »
Resource Centers
COVID-19 Resource Center

COVID-19 Resource Center

Video
Meeting News

VIDEO: How prescribing habits impact the antimicrobial market

October 3, 2019
More »